|
---|
Category:Audit Report
MONTHYEARML15266A1392015-10-13013 October 2015 Summary of the Environmental Site Audit Related to the Review of the Construction Permit Application 2015-10-13
[Table view] Category:Letter
MONTHYEARML22147A1572022-07-11011 July 2022 Northwest Medical Isotopes, LLC - Termination of Construction Permit CPMIF-002 ML22084A0042022-02-0707 February 2022 Northwest Medical Isotopes, LLC (Nwmi), Request for Termination of Construction Permit No. CPMIF-002 ML19315A0132019-11-11011 November 2019 Northwest Medical Isotopes, LLC (Nwmi) Periodic Report Required by the License Conditions in Construction Permit No. CPMIF-002 (Docket No. 50-609), November 11, 2019 ML18163A0612018-11-16016 November 2018 Letter: Approval of Request for Exemption from Requirements of Title 10 of the Code of Federal Regulations, Paragraph 70.21 (F) ML18318A3052018-11-0909 November 2018 Northwest Medical Isotopes, LLC (Nwmi) - Periodic Report Required by the License Conditions in Construction Permit No. CPMIF-002 ML18113A5042018-05-17017 May 2018 Letter to L. Tippet-Mosby Missouri Department of Natural Resources Request for Comments on North West Medical Isotopes Draft Environmental Assessment ML18037A3082018-05-0909 May 2018 Northwest Medical Isotopes, LLC - Transmittal Letter Regarding Issuance of Construction Permit for a Medical Radioisotope Production Facility ML18110A6072018-04-26026 April 2018 Acceptance for Review of Request for Exemption from Requirements of 10 CFR 70.21(F) for the Target Fabrication Portion of the Northwest Medical Isotopes Radioisotope Production Facility ML18088A1752018-03-12012 March 2018 Supplemental Information Request - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(F), Filing, for Northwest Medical Isotopes, LLC Radioisotope Production Facility ML17355A5292017-12-21021 December 2017 RIC Invitation Letter External Speaker 2018 Haass ML17362A0402017-12-18018 December 2017 Northwest Medical Isotopes, LLC - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70 21(F), Filing. ML17353A0982017-12-18018 December 2017 Letter from Missouri Department of Natural Resources Regarding Northwest Medical Isotopes, LLC Application for Construction Permit ML17349A1732017-12-14014 December 2017 Letter to Chairman Kristine Svinicki from Senators Ron Wyden and Claire Mccaskill Regarding Northwest Medical Isotopes, LLC Application for Construction Permit ML17324A4122017-12-0808 December 2017 LTR-17-0431-1 - Report on Safety Aspects of the Construction Permit Application for Nwmi Medical Radioisotope Production Facility ML17339A1972017-11-27027 November 2017 11-27-17 Ltr to Maurice Graham, Et Al., from Annette Vietti-Cook Notifying Him of That the Commission Is Convening an Evidentiary Hearing on the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facilit ML17332A6802017-11-24024 November 2017 11-24-17, Ltr to the Honorable Eric Greitens Et Al., Governor of Missouri from Denise Mcgovern Notifying Him of an Evidentiary Hearing for the Construction Permit Application Associated with Proposed Northwest Medical Isotopes Facility in C ML17331B4452017-11-22022 November 2017 11-22-17 Letter to Bill Anoatubby Et Al, Governor, Chickasaw Nation from Annette Vietti-Cook Notifying Him of the Evidentiary Hearing for the Construction Permit Application Associated with the Proposed Northwest Medical Isotopes Facility i ML17310A3662017-11-16016 November 2017 Transmittal Letter of Safety Evaluation Report for the Northwest Medical Isotopes, LLC, Constuction Permit Application ML17310B5112017-11-0606 November 2017 Report on the Safety Aspects of the Construction Permit for Northwest Medical Isotopes, LLC, Radioisotope Production Facility ML17283A1092017-09-28028 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit (TAC No. MF6138), Docket No. 50-609, Dated September 18, 2017 ML17283A1082017-09-28028 September 2017 Responses to Advisory Committee on Reactor Safeguards Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMl-2013-021, Construction Permit Application for Radioisotope Production, at Meeting on September 21, 2017 ML17262A1112017-09-21021 September 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit ML17265A0462017-09-19019 September 2017 Northwest Medical Isotopes, LLC Response to U.S. Nuclear Regulatory Commission Request for Additional Information Regarding Application for Construction Permit ML17265A0482017-09-18018 September 2017 Responses to Advisory Committee on Reactor Safeguard Questions on Docket No. 50-609, Northwest Medical Isotopes, LLC, NWMI-2013-021, Construction Permit Application/Or Radioisotope Production, at Meetings on June 19, 2017; July 11, 2017; & ML17268A3032017-09-15015 September 2017 Ltr from Missouri Dept of Natural Resources Dtd Sep 15, 2017, to Nwmi, Issuing 401 Water Quality Certification ML17221A1992017-08-0707 August 2017 Transmittal of Revision 1 of Chapters 10.0, 11.0, 12.0 (Including Appendices 12A, 12b and 12C) and 14.0 and Revision 2 of Chapters 2.0, 3.0, 6.0, 7.0, 8.0 and 13.0 of NWMI-2013-021, Construction Permit Application for Radioisotope Productio ML17193A4252017-07-0606 July 2017 Northwest Medical Isotopes, LLC - Transmittal of Revision 1 of Chapters 3.0, 6.0, 7.0, 8.0, 9.0, and 13.0 of NWMI-2013-021, Construction Permit Application for Radioisotope Production ML17158B2672017-06-0303 June 2017 Northwest Medical Isotopes, LLC - Transmittal of Revision 1 of Chapters 1.0, 2.0, 4.0, and 5.0 of NWMl-2013-021, Construction Permit Application for Radioisotope Production Facility ML17157B4112017-06-0202 June 2017 Northwest Medical Isotopes, LLC, Transmittal of Revision 2 of NWMI-2014-RPT-006, MCNP 6.1 Validations with Continuous Energy ENDF/B-VIL.1 Cross-Sections ML17111A7252017-05-30030 May 2017 Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, LLC Construction Permit Application ML17086A5822017-05-30030 May 2017 Letter from NRC to Nwmi Carolyn Haass Transmitting Nwmi Final EIS ML17132A3912017-05-24024 May 2017 Notice of Availability of the Final Environmental Impact Statement for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility Construction Permit ML17096A1832017-05-23023 May 2017 Notice of Availability of the Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application (CAC No. MF6135) to N. Fowler ML17114A2532017-05-22022 May 2017 Final EIS for Nwmi Construction Permit and Response to Comments on the Draft EIS from EPA ML17121A3562017-05-22022 May 2017 Final Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application and Response to Comments on the Draft Environmental Impact Statement ML17128A0652017-04-28028 April 2017 Northwest Medical Isotopes, LLC Responses to the NRC Environmental Request for Additional Information - Letter Dated January 25, 2017 ML17128A0662017-04-28028 April 2017 Northwest Medical Isotopes, LLC Response to the NRC Regarding the Request for Additional Information Regarding Application for Construction Permit (Letter Dated March 29, 2017) ML17069A4082017-03-29029 March 2017 Northwest Medical Isotopes, LLC Request for Additional Information Regarding Application for Construction Permit ML17061A1592017-03-22022 March 2017 Proprietary Determination Regarding Northwest Medical Isotopes Presentation November 10, 2016 ML17093A6612017-03-0606 March 2017 Northwest Medical Isotopes, LLC Responses to the U.S. Nuclear Regulatory Commission Environmental Request for Additional Information - Letter Dated January 25, 2017 ML17048A2712017-02-27027 February 2017 Northwest Medical Isotopes, LLC - Proprietary Determination Regarding Request for Information Responses Dated November 28, 2016 ML16344A0522016-11-28028 November 2016 Northwest Medical Isotopes, LLC - Responses to the U.S. Nuclear Regulatory Commission Regarding the Preliminary Safety Analysis Report Request for Additional Information ML16305A2442016-11-10010 November 2016 Maintenance of Reference Materials at the Daniel Boone Regional Library for the Environmental Review of Northwest Medical Isotopes, Llc Construction Permit Application ML16294A1352016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Construction Permit for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility ML16293A8812016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Construction Permit for the Proposed Northwest Medical Isotopes, LLC Radioisotope Production Facility ML16308A4342016-11-0707 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, Llc Radioisotope Production Facility Construction Permit Application (Cac No. MF6135) ML16295A1292016-11-0404 November 2016 Notice of Availability of Nwmi DEIS-Tribal ML16272A2942016-11-0101 November 2016 NRC to FWS Availability of the NWMI Draft EIS and Concurrence with ESA Determinations ML16294A4792016-11-0101 November 2016 Letter to Nicholas Fowler, Nwmi, Transmitting the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application ML16292A7242016-11-0101 November 2016 Notice of Availability of the Draft Environmental Impact Statement for the Northwest Medical Isotopes, LLC, Medical Radioisotope Production Facility Construction Permit Application 2022-07-11
[Table view] |
Text
C. Haass UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 October 13, 2015 Carolyn C. Haass Vice President Northwest Medical Isotopes, LLC 8815 Northwest 9th Street, Suite 256 Corvallis, OR 97330
SUBJECT:
SUMMARY OF THE ENVIRONMENTAL SITE AUDIT RELATED TO THE REVIEW OF THE CONSTRUCTION PERMIT APPLICATION FOR NORTHWEST MEDICAL ISOTOPES, LLC
Dear Ms. Haass:
On September 16-17, 2015, a review team consisting of staff from the U.S. Nuclear Regulatory Commission (NRC) participated in a site audit at the Regional Economic Development, Inc. building, 500 E Walnut St., Suite 102, Columbia, MO, related to the environmental review of Northwest Medical Isotopes, LLC's (NWMI) construction permit application for its proposed radioisotope facility. The primary goal of the site visit was to review documentation and gather information. The site audit was conducted in accordance with the issued audit plan (Agencywide Documents Access and Management System (ADAMS) Accession No. ML15202A643). A list of representatives from the Boone County Commission, the Regional Economic Development, Inc., NRC, NWMI and its contractors, and the University of Missouri Research Reactor (MURR) who participated in the site audit is provided in Enclosure 1.
The audit began on September 16, 2015, with an entrance meeting to introduce participants and to discuss logistics of the audit. Following the entrance meeting, presentations were led by NRC staff and NWMI staff. NRC staff presented an overview of the environmental review process (Enclosure 2) and NWMI presented an overview of the radioisotope production process, connected actions and modifications at the three research reactors, and the alternative site selection process. NRC staff reviewed information need responses and examined documents used by NWMI in preparation of the Environmental Report. In the afternoon, NRC staff participated in a general site tour of: the proposed facility site location, Discovery Ridge Research Park; MURR; and the alternative facility site location adjacent to MURR in Columbia, MO.
On September 17, 2015, the NRC staff met with NWMI staff to address the specific audit needs identified in the audit plan. Most of the NRC staff's questions identified in the audit plan or during the audit were answered through the conduct of the audit. Those that were not, will be answered by NWMI, as it responds to a request for additional information (RAI) letter to be issued subsequently. Furthermore, on September 17, 2015, NRC staff visited the State Historic C. Haass Preservation Office (SHPO) in Jefferson City, MO, to discuss NRC's environmental review, NRC's approach to integrating the National Environmental Policy Act (NEPA) review process and Section 106 of the National Historic Preservation Act (NHPA) review, and NWMI's construction permit application for a proposed radioisotope facility at the Discovery Ridge Research Park. The SHPO indicated that it was familiar with the proposed project, having been contacted by NWMI in 2013 regarding review of the Cultural Resource Investigations Phase 1 Survey for Discovery Ridge and concurred with the NWMI investigator's recommendation that there would be no historic properties affected.
At the conclusion of the site audit, an exit meeting was conducted and NRC staff summarized the status of the review and that any additional information necessary to support the review would be formally requested via the RAI process. The RAI letter will be made publically available in ADAMS at http://www.nrc.gov/reading-rm/adams.html. Persons who do not have access to ADAMS or who encounter problems in accessing the documents located in ADAMS should contact the NRC's Public Document Room staff at 800-397-4209 (or 301-415-4737) or by e-mail at pdr.resource@nrc.gov. If you have any questions, please contact me by telephone at 301-415-2715 or by e-mail at Nancy.Martinez@nrc.gov. Sincerely,
/RA/ Nancy Martinez, Environmental Project Manager Environmental Review and Guidance Branch Division of License Renewal Office of Nuclear Reactor Regulation Docket No. 50-609
Enclosures:
As stated cc w/encls: Listserv
ML15233A139 *concurred via email Letter to C. Haass from N. Martinez, dated October 13, 2015
SUBJECT:
SUMMARY OF THE ENVIRONMENTAL SITE AUDIT RELATED TO THE REVIEW OF THE CONSTRUCTION PERMIT APPLICATION FOR NORTHWEST MEDICAL ISOTOPES, LLC DISTRIBUTION E-mail: Public AAdams, NRR DTiktinsky, NMSS RTR r/f SLynch, NRR RJohnson, NMSS RidsNrrDpr DBarass, NSIR ASapountzis, NSIR RidsNrrDprPrta LTran, NRR LHarris, NSIR RidsNrrDprPrtb MYoung, OGC DWrona, NRR RidsAcrsAcnw_MailCTR NMartinez, NRR MBalazik, NRR RidsOgcMailCenter MMoser, NRR Hard Copy: Englewood, Colorado, 80112 Nicholas F. Fowler Chief Executive Officer Northwest Medical Isotopes, LLC 8815 Northwest 9th Street, Suite 256 Corvallis, OR 97330
Darrell Liles, CHP, PE Senior Health Physicist ARCADIS-SENES 8310 South Valley Highway Suite 135 ENCLOSURE 1 LIST OF PARTICIPANTS NORTHWEST MEDICAL ISOTOPES, LLC ENVIRONMENTAL SITE AUDIT SEPTEMBER 16-17, 2015 PARTICIPANTS ORGANIZATION John Andrzejczak Merrick & Company Michael Balazik U.S. Nuclear Regulatory Commissions (NRC) John Beller Portage Inc. Ralph Butler University of Missouri Research Reactor Stacey Button Regional Economic Development, Inc. Russell Chazell NRC Michael Corum Atkins Global Gary Dunford AEM Consulting Mike Flagg University of Missouri Research Reactor Kevin Folk NRC Carolyn Haass Northwest Medical Isotopes, LLC (NWMI) Robert Hoffman NRC Steve Lauzier University of Missouri System Nancy Martinez NRC Karen M. Miller Boone County Commission Micheal Moser NRC William Rautzen NRC Steve Reese NWMI ENCLOSURE 2